Is there such a thing as CBD overdose? Let’s look at the data.
After the passage of the Farm Bill that legalized hemp and the cannabis industry took off, the FDA approved a pharmaceutical preparation of cannabidiol. This preparation is indicated for the treatment of particular types of seizures in patients 2 years old or older. That drug is made from a plant-derived pharmaceutical grade cannabidiol (CBD) isolate that does not contain any other cannabinoids or THC
The label says that adverse events are mild: diarrhea, sleepiness, and nausea. Researchers found no untoward safety signals in the trials leading to its approval by the FDA.
Last year, a group of physicians in the UK performed a retrospective analysis of over 35 studies of CBD use in a medical context. Doses ranged from less than 1 mg/kg of body mass to more than 50 mg/kg of body mass. Other than sedation, the doctors saw no serious adverse events in the data, even at high doses.1
Earlier this year, a group in Denmark performed a look-back at clinical trials using CBD oils. Most of the studies reported no adverse effects with acute administration and only mild to moderate adverse effects with chronic administration. Anecdotal case reports show various degrees of efficacy of cbd oil and cbd tinctures low toxicity levels, and have not reported any serious side effects.
Even the World Health Organization (WHO) came to the conclusion that cbd is safe for human consumption and does not cause overdose or addiction. Studies on CBD in the United States have been limited due to federal drug laws, further clouding our ability to better understand CBD overdose and toxicity level. Cornbread Hemp advocates for less federal restrictions on studying cannabis in America.